Suppression of disease phenotypes of adult mito-mice carrying pathogenic mtDNA by bone marrow transplantation

Human Molecular Genetics
Shin-Ichi InoueJun-Ichi Hayashi

Abstract

For directly addressing the issue of gene therapy of adult patients with mitochondrial diseases, we carried out bone marrow transplantation to adult mito-mice with mutated mtDNA and expressing respiration defects for improvement of disease phenotypes. We supposed that bone marrow cells transdifferentiated into various tissues, so that their transplantation would suppress disease phenotypes. The results showed improvement of survival and delayed expression of renal failure. As most mito-mice without a transplant died due to renal failure, we examined whether transplanted bone marrow cells transdifferentiated into renal tissues carrying improved renal function. Histochemical analyses showed that the suppression of disease phenotypes was not due to transdifferentiation, but due to suppression of apoptosis of renal cells. Thus, bone marrow cells possess a novel function of supporting tissues by suppressing apoptosis induced by respiration defects.

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Jan 1, 1995·Annual Review of Genetics·N G Larsson, D A Clayton
May 5, 1997·FEBS Letters·M OkabeY Nishimune
Mar 5, 1999·Science·D C Wallace
May 15, 1999·Science·B E PetersenJ P Goff
Apr 5, 2001·Nature·D OrlicP Anversa
Jun 8, 2001·The Journal of Clinical Investigation·K A JacksonM A Goodell
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·D OrlicP Anversa
Nov 29, 2001·The Journal of Cell Biology·J PrillerU Dirnagl
Apr 5, 2002·Nature·Qi-Long YingAustin G Smith
Sep 18, 2002·Kidney International·Sandeep GuptaMark E Rosenberg
Apr 1, 2003·Nature·George VassilopoulosDavid W Russell
Jun 26, 2003·The Journal of Clinical Investigation·Sujata KaleLloyd G Cantley
Oct 14, 2003·Nature·Manuel Alvarez-DoladoArturo Alvarez-Buylla
Jun 24, 2004·Journal of the American Society of Nephrology : JASN·Marina MorigiGiuseppe Remuzzi
Sep 17, 2004·The Journal of Clinical Investigation·Juan A OliverQais Al-Awqati
Jan 27, 2005·Biochemical and Biophysical Research Communications·Keiichi HishikawaToshiro Fujita
Apr 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Akitsugu SatoJun-Ichi Hayashi
Jun 22, 2005·The Journal of Cell Biology·Keiichi HishikawaToshiro Fujita
Jul 12, 2005·The Journal of Clinical Investigation·Fangming LinPeter Igarashi
Sep 6, 2005·Biochemical and Biophysical Research Communications·Takahiko KobayashiYoshio Terada
Nov 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Akitsugu SatoJun-Ichi Hayashi

❮ Previous
Next ❯

Citations

Feb 27, 2007·PLoS Genetics·Gregory C KujothTomas A Prolla
Sep 8, 2010·Biochemical and Biophysical Research Communications·Satoshi NishiyamaHiromichi Yonekawa
Apr 15, 2016·Current Opinion in Genetics & Development·Jun-Ichi HayashiAkinori Shimizu
Aug 11, 2006·American Journal of Physiology. Cell Physiology·Shaharyar M KhanRussell H Swerdlow
Dec 14, 2018·Cancer Metastasis Reviews·Thomas C BeadnellDanny R Welch

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis